Objective: Ovarian cancer is one of the most common and lethal gynecologic malignancy. In Turkey, the 8 th most commonly seen neoplasm is ovarian cancer. The risk factors of ovarian cancer are menstrual reproductive events including gravida, menarche and menopause status, and life style habits such as cigarette smoking and habitat. In this study we aimed to determine the risk factors leading to ovarian cancer in Turkish women population and show the tumor markers in this population.
Introduction
Ovarian cancer is one of the most common and lethal gynecologic malignancy [1] . Ovarian cancer is the 7 th most frequent neoplasm in developed countries [2] . The total number of ovarian cancer cases has been estimated to be around 238719 per year in 2012 and are approximately 3.6% of all cancers in women [3, 4] in the world. In Turkey, the 8 th most commonly seen neoplasm was ovarian cancer and the incidence was estimated approximately 2400 per year (3.9%) in 2012 [3, 4] . However, the incidence in Turkey is hardly possible to access because of the insufficient statistical records.
The risk factors of ovarian cancer are menstrual reproductive events including gravida, menarche and menopause status, and life style habits such as cigarette smoking and habitat [5] . Additionally, age is pivotal for the types of ovarian cancer [6] . Early detection of ovarian cancer is much more important to improve outcomes of the disease. Epidemiological studies may support early detection and has supplied prevention, and screening methods for the ovarian cancer. Although many epidemiological studies were found in the literature about other countries, there has been no epidemiological study sited in our country.
The serum biomarkers CA-125, CA-199, CA-153 and CEA are the most widely used serum tumor markers for management of women with ovarian cancer [7] . The biological tumor markers are also used for screening, early detection, monitoring of ovarian cancer status [8] . These glycoproteins are mullerean epithelial origin that includes endosalpinx, endometrium, and endocervix. So, the benign conditions which are associated with epithelial tissues may affect these tumor markers. Additionally, there has been no consensus developed for these tumor markers.
In this study we aimed to determine the risk factors leading to ovarian cancer in Turkish women population and show the tumor markers in this population.
Materials and Methods
Current study included 311 ovarian neoplasia cases diagnosed at the Pathology Department of Ataturk University in Erzurum over last seven years extending from January 2005 to June 2013. This study is a retrospective analysis basing on the pathology reports and accesible patient files. Those cases are investigated according to their age, sex, hometown, smoking status, location of the lesion, tumor markers and histopathological diagnosis. The definition of non-smoker/never-smoker, ex smoker and smoker is designed as: never smoker/non smoker; as a person who had never smoked or had smoked <20 cigarettes in his or her lifetime, ex smoker; those who stopped smoking for more than ten years, and smoker; those who have smoked ever in their life more than just occasional smoking [9] .
Serum tumor markers including CA-125, CA-199, CA-153, CEA of the patients were retrospectively reported from their records. The cut-off values were 35 U/mL for CA-125, 30 U/mL for CA-153, 37 U/Ml for CA-199, 6 for AFP, and 2.5 for CEA [10] . Serum CA-125 values were determined as normal lower than 35 U/mL and higher more than 35 U/mL. Other tumor markers were similarly evaluated normal or higher according to the cut-off values.
The ovarian tumors were classified according to histological classification of World Health Organization (WHO) [11] . Conventional stained preparations existing in our archive examined by two pathologists as well independent of each other and histopathologic diagnosis and the distribution of the sub-group was revised (Figure 1 ). SPSS 20.0 was used for statistical analysis. Percent of the variables were compared in the groups of ovarian neoplasms. p values <0.05 were accepted as statistically significant. If the letters used for intra-group comparision are different (eg. a, b, c) indicate statistically significant (p<0.05), the same letters (eg. a, a) indicate statistically no significant ( p>0.05).
Results
A total of 311 patients were included in this study in which patients were diagnosed at the Pathology Department Table 1 . The mean age of the patients were 41.5±16.3. Borderline serous tumors (80%), mucinous cystadenoma (63%), dysgerminoma (100%), and mature teratoma (90%) were significantly seen in patients younger than 45 whereas serous adenocarcinoma (75%), borderline mucinous (100%), transitional cell carcinoma (100%), and immature teratoma (100%) were significantly found in patients older than 45 ( Figure 2 ). All cancers except dysgerminoma (20%) and mature teratoma (50%) were appeared in multigravida women. When the relationship between smoking status and tumor type was evaluated, ratio of nonsmokers were significantly higher in The different letters used for intra-group comparision (eg. a, b, c) indicate statistically significant (p<0.05), the same letters (eg. a, a) indicate statistically no significant (p>0.05).
all groups (Table 2 ). According to the age of first menarche, serous cystadenoma were seen 6.5% in age 9-10, 53.2% in age 11-12, 38.7% in age 13-14, and 1.6% in age 15-16, respectively and there was statistically significant difference between the groups. Patients with borderline serous or serous adenocarcinoma were found significantly lower ratio in 15-16 age of first menarche. Menstrual cycle of the patients with serous cystadenoma (43.5% vs. 29%), borderline serous tumor (80% vs. 10%), and mature teratoma (63.8% vs. 27.6%) was irregular. Women with serous adenocarcinoma were significantly in menapause (59.1%) ( Table 3 ). There has been no difference for the habitual status of the patients in all cancer groups, rural or urban. Although only serous cystadenoma were statistically significant seen in right ovary, tumors were mostly located in the right ovary (Figure 3) . The association between tumor markers and types of ovarian neoplasia were (Table 4 ). In the all tumor groups, all of the tumor markers were significantly normal.
Discussion
One of the leading cause of cancer related death in women is ovarian cancer with 151905 deaths of world (4.3%) [3, 4] . The sub-group named as ovarian surface epithelial tumors are the most common lethal gynecologic neoplasms for women of reproductive age and older and these tumors display biological behaviors that follow their histopathological grading of malignant, borderline or low malignant potential, or benign [12] In Turkey, the number of mortality due to ovarian cancer was 1588 women (4.8%) [3, 4] . But there were conflicting data about the insidence in Turkey because of insufficient recording system. After the endometrium cancer, ovarian cancer is the second commonly seen malignancy in Turkey. Approximately 90% of ovarian cancers are derived from tissues that come from the coelomic epithelium or mesothelium [13] . Serous cystadenoma is the commonest ovarian tumor followed by mucinous, germ cell tumors, and dysgerminoma. In our study, Most of the studies reported that the age of the women positively associated with ovarian cancer [14, 15] . Similarly, our fundings supported the other epidemiological studies.
Comparison of the age distribution of ovarian neoplasia cases revealed that benign ovarian neoplasms were significantly found in women lower than 45 whereas malign neoplasms were accompanied with women higher than 45 in our study. More than 80% of epithelial ovarian cancers are found in postmenopausal women and the peak incidence of invasive epithelial ovarian cancer is at 56 to 60 years of age [13] . These cancers are relatively uncommon in women younger than age 45. Benign ovarian neoplasms and borderline tumors which are associated with a very good prognosis occur predominantly in premenopausal women [16] .
Although most of studies in the literature claimed that cigarette smoking was associated with an incresed risk factor for ovarian cancers, especially mucinous epithelial ovarian cancer [17] [18] [19] , Goodman and Tung reported that active tobacco smoking was not a risk factor for invasive ovarian cancer [20] . In a recent large population study, epithelial ovarian cancer did not observe an association with smoking [21] Our results confirm that smoking may not increase the risk of ovarian cancer. However, this study was not based on cigarette smoking and did not search the insidence of ovarian cancer in cigarette smoking women.
Early menarche and low parity were associated with increased risk of ovarian cancer [22] . In a population based case control study, ≤13 age at menarche was significantly related to the risk of ovarian cancer [23] . Although protective effect of parity is unclear, duration of menstrual cycle in life is inversely associted with ovarian cancer, having at least one child is protective of the disease, with a risk reduction of 0.3 to 0.4 [13] . The protection effect of oral contraceptives against epithelial ovarian cancer that was well established in the literature have the similar mechanism [24, 22] . In our study, epithelial ovarian neoplasms were mostly associated with early menarche whereas the ratios of all groups were higher according to the gravida.
Although several lifestyle factors affect a woman's risk of ovarian cancer, the most important risk factor, family history of disease, is unlikely to be related to socio-economic status. Urban areas had higher incidence rates, compared to rural areas, across all deprivation levels [25] . Similarly, our study showed that there was no difference for the insidence of habitual status, urban and rural.
Tung et al. [26] revealed that lifetime ovulation was significantly and positively associated with the risk of ovarian cancer. Their data provide the clear evidence for the hypothesis that ovulation is integral to the etiology of ovarian cancer. Therefore, factors that induced anovulation, including oral contraceptives, pregnancy, and breastfeeding, were associated with a reduced risk of ovarian cancer. Despite our study displayed that menstrual irregularity was frequent in the ovarian malignancy. An important limitation of this study is that we examined menstrual irregularity in the women with ovarian cancer.
The clinical diagnosis and following of ovarian cancer depends on the clinical findings and image examination, however, ovarian cancer can hardly be diagnosed at early stage and monitarization after first treatment is vital [27, 28] . Early diagnosis decrease the morbidity and mortality of ovarian cancer. However, most serum tumor markers are neither sensitive nor specific enough for cancer diagnosis. CA-125 is used to diagnose and follow up epithelial ovarian cancer especially serous adenocarcinoma. CA-199 is Granulosa cell carcinoma (n=6) 100 0 100 0 100 0 100 0 100 0
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